The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mirum Pharmaceuticals Inc shares valued at $3,700,000 were sold by GREY MICHAEL G on Dec 01 ’25. At $74.00 per share, GREY MICHAEL G sold 50,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, MICHAEL GREY purchased 50,000 shares, netting a total of over 3,700,000 in proceeds.
Before that, GREY MICHAEL G had sold 50,000 shares from its account. In a trade valued at $3,500,000, the Director traded Mirum Pharmaceuticals Inc shares for $70.00 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $0.0.
As published in their initiating research note from TD Cowen on September 24, 2025, Mirum Pharmaceuticals Inc [MIRM] has been a Buy and the price target has been revised to $95. Earlier on April 17, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for MIRM stock.
Analyzing MIRM Stock Performance
On last trading session, Mirum Pharmaceuticals Inc [NASDAQ: MIRM] rose 1.59% to $70.99. The stock’s lowest price that day was $69.9726, but it reached a high of $71.815 in the same session. During the last five days, there has been a drop of approximately -1.07%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 53.59%. Shares of the company reached a 52-week high of $78.54 on 10/09/25 and a 52-week low of $36.88 on 04/09/25.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 70.04, which, if violated, would cause prices to drop to 69.08. In the upper region, resistance lies at 71.88. The next price resistance is at 72.77. RSI (Relative Strength Index) is 49.47 on the 14-day chart, showing neutral technical sentiment.
Is Mirum Pharmaceuticals Inc subject to short interest?
Stocks of Mirum Pharmaceuticals Inc saw a sharp rise in short interest on 2025-11-14 jumping by 0.27 million shares to 7.66 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 7.39 million shares. A jump of 3.55% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 13.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 13.35.
Which companies own the most shares of Mirum Pharmaceuticals Inc (MIRM)?
In terms of Mirum Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 89 in the next 12 months, up nearly 27.36% from the previous closing price of $69.88. Analysts anticipate Mirum Pharmaceuticals Inc stock to reach 95 by 2025, with the lowest price target being 81. In spite of this, 9 analysts ranked Mirum Pharmaceuticals Inc stock as Buy at the end of 2025. On December 18, 2023, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $58.
